Literature DB >> 22890249

Association of cystic fibrosis transmembrane conductance regulator gene variants with acute lung injury in African American children with pneumonia*.

Julie M Baughn1, Michael W Quasney, Pippa Simpson, Daniel Merchant, Shun-Hwa Li, Hara Levy, Mary K Dahmer.   

Abstract

OBJECTIVES: The cystic fibrosis transmembrane conductance regulator regulates fluid balance in alveolar epithelial cells and appears to modulate the inflammatory response. To determine whether more severe lung injury in children who develop community-acquired pneumonia is associated with variations known to affect function in the gene coding for cystic fibrosis transmembrane conductance regulator.
DESIGN: A prospective cohort genetic association study of lung injury in children with community-acquired pneumonia.
SETTING: Three major tertiary care children's hospitals.
SUBJECTS: Caucasian and African American children with community-acquired pneumonia either evaluated in the emergency department or admitted to the hospital.
INTERVENTIONS: None.
MEASUREMENTS AND MAIN RESULTS: Caucasian and African American children with pneumonia were genotyped for the most common variants reported to affect cystic fibrosis transmembrane conductance regulator function, the p.508del mutation, the (TG)mTn variable repeat region, and the M470V polymorphism in the cystic fibrosis transmembrane conductance regulator gene. Genotypes and haplotypes were determined, and the association of high-risk alleles or high-risk haplotypes (defined as the presence of at least one variant known to decrease the level of functional cystic fibrosis transmembrane conductance regulator) with the need for mechanical ventilation or the development of acute lung injury was evaluated. Forty-two children in the Caucasian cohort (n = 304) required mechanical ventilation; 32 developed acute lung injury. Forty-three children in the African American cohort (n = 474) required mechanical ventilation; 29 developed acute lung injury. In African American children, high-risk (TG)mTn alleles known to result in decreased levels of functional cystic fibrosis transmembrane conductance regulator were associated with the need for mechanical ventilation (p = .0013) and the development of acute lung injury (p = .0061). Multivariable analysis demonstrated that high-risk (TG)mTn alleles were independently associated with mechanical ventilation (odds ratios = 3.19; 95% confidence interval, 1.63-6.26) and acute lung injury (odds ratios = 3.36; 95% confidence interval, 1.50-7.53) in African American children.
CONCLUSION: Genetic variation in cystic fibrosis transmembrane conductance regulator is associated with acute lung injury in African American children with community-acquired pneumonia.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22890249      PMCID: PMC4273667          DOI: 10.1097/CCM.0b013e31825d8f73

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  56 in total

1.  A new statistical method for haplotype reconstruction from population data.

Authors:  M Stephens; N J Smith; P Donnelly
Journal:  Am J Hum Genet       Date:  2001-03-09       Impact factor: 11.025

2.  Sample size requirements for matched case-control studies of gene-environment interaction.

Authors:  W James Gauderman
Journal:  Stat Med       Date:  2002-01-15       Impact factor: 2.373

3.  Activation of NF-kappaB in airway epithelial cells is dependent on CFTR trafficking and Cl- channel function.

Authors:  A J Weber; G Soong; R Bryan; S Saba; A Prince
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2001-07       Impact factor: 5.464

4.  Non-specific activation of the epithelial sodium channel by the CFTR chloride channel.

Authors:  G Nagel; T Szellas; J R Riordan; T Friedrich; K Hartung
Journal:  EMBO Rep       Date:  2001-03       Impact factor: 8.807

5.  Mutation analysis of the cystic fibrosis and cationic trypsinogen genes in patients with alcohol-related pancreatitis.

Authors:  K G Monaghan; C E Jackson; D L KuKuruga; G L Feldman
Journal:  Am J Med Genet       Date:  2000-09-11

6.  Inflammation and infection in naive human cystic fibrosis airway grafts.

Authors:  R Tirouvanziam; S de Bentzmann; C Hubeau; J Hinnrasky; J Jacquot; B Péault; E Puchelle
Journal:  Am J Respir Cell Mol Biol       Date:  2000-08       Impact factor: 6.914

7.  Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9.

Authors:  E Buratti; F E Baralle
Journal:  J Biol Chem       Date:  2001-07-24       Impact factor: 5.157

8.  Novel role for CFTR in fluid absorption from the distal airspaces of the lung.

Authors:  X Fang; N Fukuda; P Barbry; C Sartori; A S Verkman; M A Matthay
Journal:  J Gen Physiol       Date:  2002-02       Impact factor: 4.086

9.  Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element.

Authors:  F Pagani; E Buratti; C Stuani; M Romano; E Zuccato; M Niksic; L Giglio; D Faraguna; F E Baralle
Journal:  J Biol Chem       Date:  2000-07-14       Impact factor: 5.157

10.  Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping.

Authors:  E Buratti; T Dörk; E Zuccato; F Pagani; M Romano; F E Baralle
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

View more
  2 in total

1.  Interpretation of gene associations with risk of acute respiratory distress syndrome: P values, Bayes factors, positive predictive values, and need for replication.

Authors:  Sebastian Rimpau; Ari R Joffe
Journal:  Crit Care       Date:  2016-12-21       Impact factor: 9.097

2.  Association of polymorphisms in genes of factors involved in regulation of splicing of cystic fibrosis transmembrane conductance regulator mRNA with acute respiratory distress syndrome in children with pneumonia.

Authors:  Francesca Perez-Marques; Pippa Simpson; Ke Yan; Michael W Quasney; Nadine Halligan; Daniel Merchant; Mary K Dahmer
Journal:  Crit Care       Date:  2016-09-05       Impact factor: 9.097

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.